A 12-point checklist in the design and practical application of active surveillance of diseases in aquatic organisms (farmed and wild) has been developed to serve as a methodological approach and guidance for a multidisciplinary team particularly in countries where surveillance expertise is limited. The checklist is based on a review of available main aquatic surveillance references and scientific literature and was further developed based on the outcomes of several aquaculture biosecurity project-related workshops hosted by the Food and Agriculture Organization of the United Nations. The checklist includes the following: (1) scenario setting;(2) defining surveillance objective; (3) defining the populations; (4) disease clustering; (5) case definition; (6) diagnostic testing; (7) study design and sampling; (8) data collection and management; (9) data analysis; (10) validation and quality assurance; (11) human and financial resources and logistics requirements; and (12) surveillance in the bigger picture. For a multidisciplinary approach to disease control, knowledge of fish biology, aquaculture systems and many aspects of aquaculture health management are required. Surveillance needs significant financial investment and must be supported by adequate diagnostic capability, information system management, legal framework and communication networks, with transparent reporting mechanisms to allow rapid disease response for serious diseases of aquatic organisms. It is a stepwise and pragmatic approach that offers a good starting point for addressing disease issues especially in developing countries. It can be used as a model to build targeted surveillance competency and a basic reference when implementing a surveillance programme or improving existing programmes.

Beta lactam antibiotics are widely used in therapy of cattle, particularly for the treatment of mastitis.  Over 95% of residue testing in dairies in Bosnia and Herzegovina is for Beta lactams. The aim of this paper is to compare the efficacy of three most common screening tests for Beta lactam residues in cow's milk in our country. The tests used in the study are SNAP β Lactam test (Idexx), Rosa Charm β Lactam test and Inhibition MRL test. Study samples included: standardized concentrations of penicillin solution (0, 2, 3, 4, 5 and 6 ppb). In addition we tested milk samples from three equal size study groups (not receiving any antibiotic therapy, treated with Beta lactams for mastitis and treated with Beta lactams for diseases other than mastitis). Sensitivity and specificity were determined for each test, using standard penicillin concentrations with threshold value set at concentration of 4 ppb (Maximum residue level - MLR). Additionally we determined proportions of presumably false negative and false positive results for each test using results of filed samples testing. Agreement of test results for each test pair was assessed through Kappa coefficients interpreted by Landis-Koch scale. Detection level of all tests was shown to be well below MRL. This alongside with effects of natural inhibitors in milk contributed to finding of positive results in untreated and treated animals after the withholding period. Screening tests for beta lactam residues are important tools for ensuring that milk for human consumption is free from antibiotics residues.

The COST action “Standardising output-based surveillance to control non-regulated diseases of cattle in the European Union (SOUND control),” aims to harmonise the results of surveillance and control programmes (CPs) for non-EU regulated cattle diseases to facilitate safe trade and improve overall control of cattle infectious diseases. In this paper we aimed to provide an overview on the diversity of control for these diseases in Europe. A non-EU regulated cattle disease was defined as an infectious disease of cattle with no or limited control at EU level, which is not included in the European Union Animal health law Categories A or B under Commission Implementing Regulation (EU) 2020/2002. A CP was defined as surveillance and/or intervention strategies designed to lower the incidence, prevalence, mortality or prove freedom from a specific disease in a region or country. Passive surveillance, and active surveillance of breeding bulls under Council Directive 88/407/EEC were not considered as CPs. A questionnaire was designed to obtain country-specific information about CPs for each disease. Animal health experts from 33 European countries completed the questionnaire. Overall, there are 23 diseases for which a CP exists in one or more of the countries studied. The diseases for which CPs exist in the highest number of countries are enzootic bovine leukosis, bluetongue, infectious bovine rhinotracheitis, bovine viral diarrhoea and anthrax (CPs reported by between 16 and 31 countries). Every participating country has on average, 6 CPs (min–max: 1–13) in place. Most programmes are implemented at a national level (86%) and are applied to both dairy and non-dairy cattle (75%). Approximately one-third of the CPs are voluntary, and the funding structure is divided between government and private resources. Countries that have eradicated diseases like enzootic bovine leukosis, bluetongue, infectious bovine rhinotracheitis and bovine viral diarrhoea have implemented CPs for other diseases to further improve the health status of cattle in their country. The control of non-EU regulated cattle diseases is very heterogenous in Europe. Therefore, the standardising of the outputs of these programmes to enable comparison represents a challenge.

More than 30 dog parasite species have been identified in Bosnia and Herzegovina so far, and half of these are zoonotic. The aim of the study was to investigate the occurrence of parasitic infections in dogs from Bosnian-podrinje canton with a focus on zoonotic parasites. The study included 212 dogs (107 owned and 105 stray). One or more of the twenty parasite species were found in 82.55% of tested samples. Dicrocoelium dendriticum (Class Trematoda) was found in 0.94% of dogs. Dipylidium caninum and Mesocestoides lineatus (Class Cestoda) were found in 7.55% and 0.94% of dogs, respectively. Taenia spp. and Echinococcus spp. (Family Taeniidae) were found in 0.47% and 0.94% of samples, respectively. In the family of Nematoda, the following parasite species were identified with corresponding percent among tested dogs: Toxocara canis (25.94%), Toxascaris leonine (8.96%), Strongyloides stercoralis (0.47%), Ancylostoma caninum (3.77%), Uncinaria stenocephala (52.36%), Trichuris vulpis (22.17%), Eucoleus aerophilus (1.42%), Dirofilaria immitis (1.89%) and Dirofilaria repens (1.42%). In the kingdom of Protozoa, the following parasite species were identified with corresponding percent among tested dogs: Cystoisospora canis (8.49%), C. ohioensis (2.36%), Cryptosporidium spp. (4.72%), Sarcocystis spp. (0.47%), Babesia spp. (5.19%), and Giardia duodenalis (15.57%). Leishmania infantum was not identified in tested samples. The results showed a high level of parasitic infestation in the dog population in the Bosnian-Podrinje canton, with a high occurrence of zoonotic parasites. Significant differences were found between owned and stray dogs for all classes of detected parasites with exception of the class Trematoda, disregarding specific parasite species.

Zoonotic parasites and vector-borne zoonotic parasitoses of humans, especially when affecting immunocompromised persons mobilize researchers’ interest and increase parasitological, environmental, and interdisciplinary investigations worldwide. Climate, environmental and anthropomorphic influences had affected the distribution, occurrence, and adaptability of parasites in humans and animals, the level of environmental contamination with parasites and their developing forms, and the surge of vector competency. Knowledge of parasite biology and evolution shows that hybridization phenomena and adaptations may cause genetic diversity, affecting parasite virulence, antiparasitic drug resistance, acclimatization to new host species, and environmental conditions previously not recorded while leading to the emergence of new diseases and changing parasitism epidemiology. Many parasitic infections are emerging or re-emerging and are neglected with deliberating consequences for public and animal health as well as for food safety and security, especially in sub capacitated developing countries. Decrease of exposure of both animals and humans and negative consequences of zoonotic parasitoses requires raising awareness of researchers, policymakers, and the wider public. Modern diagnostic methods, surveillance, monitoring of parasitoses, and early detection systems followed by tailored containment and control actions provide grounds for sane assessments and investigation toward the cost-effective and efficient prevention programs for both human and animal populations.